As featured in…
Latest Press Releases
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
Company surpasses $3M in accepted investments CHICAGO – September 16, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced it has modified its Regulation A+ (Mini-IPO) offering following a successful September re-launch. BIOLIFE4D has raised more than $3M in equity crowdfunding investments since February of 2018. …
BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart
Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO – September 9, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its…
BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand
Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO – September 6, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its second Regulation A+…
Recent Blogs
52 Years After First Heart Transplant, and there’s Still Room for Innovation!
This week, 52 years ago, Dr. Christiaan Barnard successfully performed the first heart donor transplant on Lewis Washkansky, a South African man dying of heart disease. A modern miracle of its time, Dr. Barnard’s successful surgery provided hope to those suffering from this debilitating disease, while also laying the groundwork for future generations of development…
This Thanksgiving, We Have So Much to Be Thankful For
From our team at BIOLIFE4D, we want to wish you (an early) happy and healthy Thanksgiving! The Thanksgiving holiday is a great time to catch up with loved ones, feast on your favorite food, and for many, watch football. Above all, it’s an important time to reflect and express gratitude – which is exactly what…
Top Questions to Ask your Cardiologist During Your Visit
Guest Postby Birney Jimm Heart disease is still the leading cause of death for individuals in the United States, with men being more vulnerable than women, reports the Centers for Disease Control and Prevention (CDC). One in every four deaths in the US is attributed to heart disease, which totals to about 610,000 per annum. If…
BIOLIFE4D in the News!
This Company Has Our Hearts – Steven Morris – BIOLIFE4D
Be in the know about BIOLIFE4D and the progress made so far – this is the company that has our hearts! To learn more, CLICK HERE.
BIOLIFE4D CEO Says Firm ‘One Step Closer’ to 3D Printing a Viable Human Heart
By Spencer Feingold | Oct 9 | Cheddar An Illinois-based biomedical technology firm, BIOLIFE4D, reached a watershed moment last month after successfully 3D bioprinting a miniaturized human heart. While not intended for human transplants, the mini heart was a major breakthrough in bioprinting and is expected to have broad implications for pharmaceutical testing. To Read…
A Chicago Biotech Startup’s “Mini-Heart” Could Mean Big Things for 3D Bioprinting
By Steven Ghosett, Sept. 6, 2019 “Our goal is to have this technology available to the people that need it the most and provide a life-saving option for these patients,” he said. “As with any new technology, it should be monitored so it’s not exploited for the wrong purposes.” To reach more, CLICK HERE.
BIOLIFE4D OVERVIEW
PRESS KIT
BIOLIFE4D welcomes the opportunity to speak with the media about bioprinting, its equity crowdfunding raise efforts and how building hearts will save lives.
